Access the full text.
Sign up today, get DeepDyve free for 14 days.
W. Krause, P. Muschick, U. Krüger (2002)
Use of Near-Infrared Reflection Spectroscopy to Study the Effects of X-Ray Contrast Media on Renal Tolerance in Rats: Effects of a Prostacyclin Analogue and of Phosphodiesterase InhibitorsInvestigative Radiology, 37
P. Best, R. Lennon, H. Ting, M. Bell, C. Rihal, D. Holmes, P. Berger (2002)
The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions.Journal of the American College of Cardiology, 39 7
M. Brezis, S. Rosen (1995)
Hypoxia of the renal medulla--its implications for disease.The New England journal of medicine, 332 10
S. Heyman, S. Rosen, M. Brezis (1994)
Radiocontrast nephropathy: a paradigm for the synergism between toxic and hypoxic insults in the kidney.Experimental nephrology, 2 3
P. Liss, A. Nygren, U. Olsson, H. Ulfendahl, U. Erikson (1996)
Effects of contrast media and mannitol on renal medullary blood flow and red cell aggregation in the rat kidney.Kidney international, 49 5
Cockcroft Dw, Gault Mh (1976)
Prediction of Creatinine Clearance from Serum CreatinineNephron, 16
R. Birck, S. Krzossok, F. Markowetz, P. Schnülle, F. Woude, C. Braun (2003)
Acetylcysteine for prevention of contrast nephropathy: meta-analysisThe Lancet, 362
E. Karlsson, A. Kinman, C. Sonnhag (2004)
Comparative evaluation of intravenous phenytoin, procainamide and practolol in the acute treatment of ventricular arrhythmiasEuropean Journal of Clinical Pharmacology, 11
M. Breyer (1998)
Prostaglandin Receptors in the Kidney: A New Route for Intervention?Nephron Experimental Nephrology, 6
MH Sketch, A Whelton, E Schollmayer, JA Koch, PJ Bernink, F Woltering (2001)
Prostaglandin E1 Study Group: prevention of contrast media-induced renal dysfunction with prostaglandin E1: a randomized, double-blind, placebo-controlled studyAm J Ther, 8
M. Paller, J. Manivel, Marshalleen Patten, Marian Barry (1992)
Prostaglandins protect kidneys against ischemic and toxic injury by a cellular effect.Kidney international, 42 6
R. Workman, M. Shaff, R. Jackson, J. Diggs, M. Frazer, C. Briscoe (1983)
Relationship of renal hemodynamic and functional changes following intravascular contrast to the renin-angiotensin system and renal prostacyclin in the dog.Investigative radiology, 18 2
R. Solomon, Craig Werner, Denise Mann, J. D'Elia, P. Silva (1994)
Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents.The New England journal of medicine, 331 21
K. Spargias, E. Alexopoulos, S. Kyrzopoulos, Panayiotis Iacovis, D. Greenwood, A. Manginas, V. Voudris, G. Pavlides, C. Buller, D. Kremastinos, D. Cokkinos (2004)
Ascorbic Acid Prevents Contrast-Mediated Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or InterventionCirculation, 110
Y. Itoh, T. Yano, T. Sendo, R. Oishi (2005)
Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media.Journal of pharmacological sciences, 97 4
A. Berns (1989)
Nephrotoxicity of contrast media.Kidney international, 36 4
T. Yano, Y. Itoh, T. Kubota, T. Sendo, R. Oishi (2004)
A prostacyclin analog beraprost sodium attenuates radiocontrast media-induced LLC-PK1 cells injury.Kidney international, 65 5
L. Gruberg, G. Mintz, R. Mehran, G. Dangas, A. Lansky, K. Kent, A. Pichard, L. Satler, M. Leon (2000)
The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency.Journal of the American College of Cardiology, 36 5
M. Lifschitz, J. Barnes (1984)
Prostaglandin I2 attenuates ischemic acute renal failure in the rat.The American journal of physiology, 247 5 Pt 2
R. Solomon (2005)
The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients.Kidney international, 68 5
P. McCullough, Robert Wolyn, L. Rocher, R. Levin, W. O’Neill (1997)
Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality.The American journal of medicine, 103 5
Detlef Schlondorff (1986)
Renal prostaglandin synthesis. Sites of production and specific actions of prostaglandins.The American journal of medicine, 81 2B
M. Maeder, M. Klein, T. Fehr, H. Rickli (2004)
Contrast nephropathy: review focusing on prevention.Journal of the American College of Cardiology, 44 9
R. Türker, E. Demirel, Z. Ercan (1988)
Iloprost preserves kidney function against anoxia.Prostaglandins, leukotrienes, and essential fatty acids, 31 1
C. Rihal, S. Textor, D. Grill, P. Berger, H. Ting, P. Best, Mandeep Singh, M. Bell, G. Barsness, V. Mathew, K. Garratt, D. Holmes (2002)
Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary InterventionCirculation: Journal of the American Heart Association, 105
R. Heller, G. Werner-Felmayer, E. Werner (2006)
Antioxidants and endothelial nitric oxide synthesisEuropean Journal of Clinical Pharmacology, 62
S Moncada, JR Vane (1981)
Prostacyclin and blood coagulationDrugs, 21
M. Abramovitz, Y. Boie, Tuan Nguyen, T. Rushmore, M. Bayne, K. Metters, D. Slipetz, R. Grygorczyk (1994)
Cloning and expression of a cDNA for the human prostanoid IP receptor.The Journal of biological chemistry, 269 16
MD Breyer (1998)
Prostaglandin receptors in the kidney: a new route for interventionExp Nephrol, 6
T. Fujita, Y. Fuke, A. Satomura, M. Hidaka, I. Ohsawa, M. Endo, K. Komatsu, H. Ohi (2001)
PGl2 analogue mitigates the progression rate of renal dysfunction improving renal blood flow without glomerular hyperfiltration in patients with chronic renal insufficiency.Prostaglandins, leukotrienes, and essential fatty acids, 65 4
Y. Agmon, Hagit, Peleg, Z. Greenfeld, Seymour Rosen, M. Brezis (1994)
Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat.The Journal of clinical investigation, 94 3
M. Sketch, A. Whelton, E. Schollmayer, Jens Koch, P.J. Bernink, F. Woltering, J. Brinker (2001)
Prevention of Contrast Media-Induced Renal Dysfunction With Prostaglandin E 1 : A Randomized, Double-Blind, Placebo-Controlled StudyAmerican Journal of Therapeutics, 8
Ruddle Fh, P. MeeraKhan (1976)
Report of the committee on the genetic constitution of autosomes other than chromosomes 1,2 and 6.Birth defects original article series, 12 7
S. Morgera, Rajko Woydt, H. Kern, M. Schmutzler, K. Dejonge, A. Lun, W. Rohde, W. Konertz, W. Kox, H. Neumayer (2002)
Low-dose prostacyclin preserves renal function in high-risk patients after coronary bypass surgeryCritical Care Medicine, 30
M. Rudnick, S. Goldfarb (2003)
Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality.Reviews in cardiovascular medicine, 4 Suppl 5
T. Yano, Y. Itoh, T. Kubota, T. Sendo, T. Koyama, T. Fujita, K. Saeki, A. Yuo, R. Oishi (2005)
A prostacyclin analog prevents radiocontrast nephropathy via phosphorylation of cyclic AMP response element binding protein.The American journal of pathology, 166 5
M. Kömhoff, M. Kömhoff, Britta Lesener, Britta Lesener, K. Nakao, K. Nakao, H. Seyberth, H. Seyberth, R. Nüsing, R. Nüsing (1998)
Localization of the prostacyclin receptor in human kidney.Kidney international, 54 6
R. Zusman, J. Crow, A. Cato, N. Tolkoff-Rubin (1981)
Effects of prostacyclin infusion in uremic patients: Hematologic and hemodynamic responsesClinical Pharmacology & Therapeutics, 30
Fredrick Wigley, R. Wise, J. Seibold, D. McCloskey, G. Kujala, T. Medsger, V. Steen, J. Varga, S. Jimenez, M. Mayes, P. Clements, S. Weiner, J. Porter, M. Ellman, C. Wise, L. Kaufman, John Williams, W. Dole (1994)
Intravenous Iloprost Infusion in Patients with Raynaud Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Placebo-controlled, Double-Blind StudyAnnals of Internal Medicine, 120
The results of this pilot study suggest that prophylactic administration of iloprost may effectively prevent CMN, but higher dosages are connected with substantial tolerability issues.
European Journal of Clinical Pharmacology – Springer Journals
Published: Jul 11, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.